Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5529_Библиотеки_им_академика_М_И_Перельмана
.pdf
4 Bioinformatics of Autoimmune Diseases
FIGURE 1.3 Pattern recognition and activation.
Figure 1.3 illustrates the process of pattern recognition and activation in the innate immune
system. It begins with the detection of PAMPs or DAMPs, which are conserved molecular motifs
found on microbes or released from damaged host cells, respectively. These signals are recognized
by PRRs located on the surface or within innate immune cells. Upon engagement, PRRs initiate
intracellular signaling cascades that culminate in the activation of inammatory pathways. This
leads to the production and release of pro-inammatory cytokines, chemokines, and other mediators, resulting in localized inammation and the recruitment of additional immune cells to the site
of infection or tissue injury. This mechanism forms the foundation of the innate immune response,
allowing for rapid and targeted defense against a wide range of insults.
1.2.2 ADAPTIVE IMMUNE SYSTEM
The adaptive immune system represents an advanced arm of vertebrate immunity, characterized by its specicity, diversity, and capacity for immunological memory. Unlike the broadly
targeted responses of innate immunity, adaptive responses are precisely directed against individual antigens, made possible by the generation of unique antigen receptors through somatic
gene rearrangement. This process allows for an extensive repertoire of B and T lymphocytes,
each capable of recognizing distinct molecular features of pathogens (Murphy & Weaver, 2016).
A dening feature of adaptive immunity is memory (the ability to respond more rapidly and effectively upon re-exposure to the same antigen) which forms the foundation of long-term immunity
and vaccination.
Adaptive responses are carried out by two main classes of lymphocytes. B cells, which mature
in the bone marrow, mediate humoral immunity by producing antigen-specic antibodies. T cells,
which mature in the thymus, orchestrate cell-mediated immunity and carry out diverse regulatory
and effector roles. Although they operate through different mechanisms, B and T cells work in concert to eliminate pathogens and establish long-lasting protection.
5 Immune Mechanisms and Major Autoimmune Diseases
FIGURE 1.4 TCR embedded in the T-cell membrane, composed of an alpha and a beta chain. Each chain
contains a variable (V) region responsible for antigen recognition and a constant (C) region that provides
structural support and mediates association with the CD3 signaling complex.
1.2.2.1 T Cells
T lymphocytes, or T cells, are central to the adaptive immune response. They originate from hematopoietic stem cells in the bone marrow and undergo maturation in the thymus, where they are subjected to rigorous selection processes to ensure self-tolerance and functional competence. During
positive selection, T cells capable of recognizing self-MHC molecules are retained, while negative
selection eliminates those that react strongly to self-antigens, thereby minimizing the risk of autoimmunity. Once mature, T cells enter circulation and patrol the body for signs of infection or cellular abnormalities.
Each T cell expresses a unique T cell receptor (TCR) on its surface, allowing it to recognize
peptide antigens presented by MHC molecules on APCs (see Figure 1.4). Most T cells express αβ
TCRs, composed of alpha and beta chains that together form the antigen-binding site. A smaller
subset expresses γδ TCRs and is involved in more innate-like immune functions. The TCR is a
membrane-bound glycoprotein composed of variable and constant domains, with the variable
regions conferring antigen specicity. This highly specic recognition mechanism enables T cells
to detect and respond to infected or transformed cells with precision.
The remarkable specicity and diversity of the TCR arise from somatic recombination, a precisely regulated process that occurs during T-cell development in the thymus. This mechanism
involves the random assembly of gene segments to generate a unique recombinant gene for each
TCR chain. In humans, the four TCR chain loci are distributed across two chromosomes: TRA
(TCR alpha) and TRD (TCR delta) reside on chromosome 14, while TRB (TCR beta) and TRG
(TCR gamma) are located on chromosome 7 (see Figure 1.5). These loci are composed of modular
gene segments classied as V (variable), D (diversity), and J (joining), which recombine to form the
variable region of the receptor.
Rearrangement is mediated by the recombination-activating genes RAG-1 and RAG-2, which
introduce double-stranded DNA breaks at recombination signal sequences (RSSs), enabling segmental recombination and assembly of an antigen-specic TCR (Murphy & Weaver, 2016). In the
TRA and TRG loci, which lack D segments, recombination occurs between V and J segments.
In contrast, the TRB and TRD loci utilize V–D–J recombination to generate more structurally
6 Bioinformatics of Autoimmune Diseases
FIGURE 1.5 Schematic representation of somatic recombination, RNA splicing, and translation involved in
the formation of the TCRβ chain. The variable region of the β chain is assembled through the recombination
of one V (variable), one D (diversity), and one J (joining) gene segment. This recombined DNA is transcribed
and spliced to a downstream constant (C) region exon, producing a mature mRNA transcript that is subsequently translated into the TCRβ polypeptide.
complex chains. Notably, the TRD locus is embedded within the TRA locus but is recombined
independently to produce the delta chain.
The antigen specicity of the TCR is concentrated in the variable domain, particularly in the
complementarity-determining regions (CDRs). CDR1 and CDR2 are encoded within the V segment
and interact primarily with the MHC molecule, while CDR3 (formed at the junctions of V, D (if
present), and J segments) is the most diverse region and directly contacts the antigen. This combinatorial assembly, along with junctional diversity, generates an expansive TCR repertoire capable of
recognizing a wide array of antigens.
TCR diversity arises from the recombination of V, D, and J gene segments, further amplied
by junctional diversity (random nucleotide additions and deletions at segment junctions). Unlike
B cells, T cells do not undergo somatic hypermutation (SHM) or class switching, so their antigen
specicity is xed during thymic development. The resulting repertoire is extraordinarily diverse,
with the potential to generate 108–10
10
unique TCRs capable of recognizing a vast range of peptide–
MHC complexes.
T cells differentiate into functional subsets, including CD4+ helper, CD8+ cytotoxic, memory,
γδ, and natural killer T (NKT) cells, each playing a distinct role in immune regulation and defense.
1.2.2.1.1 Helper T Cells
+
Helper T cells (CD4
) are central to adaptive immunity, directing responses through specialized
effector subsets formed upon antigen recognition and co-stimulation. These subsets include Th1,
Th2, Th17, T follicular helper (Tfh) cells, and regulatory T cells (Tregs), each dened by distinct
cytokine proles and functions.
7 Immune Mechanisms and Major Autoimmune Diseases
Th1 cells promote cell-mediated immunity against intracellular pathogens, while Th2 cells
enhance humoral responses and defense against extracellular parasites. Th17 cells protect mucosal
surfaces from bacteria and fungi, but their dysregulation is linked to autoimmune diseases. Tfh
cells aid B cells in afnity maturation and class switching within germinal centers, and aberrant
Tfh activity contributes to autoantibody production. Tregs, expressing FOXP3, maintain immune
tolerance by suppressing autoreactive T cells through contact-dependent mechanisms and cytokines
like IL-10 and transforming growth factor-beta (TGF-β). Impaired Treg function is associated with
multiple autoimmune disorders, highlighting their therapeutic potential.
1.2.2.1.2 Cytotoxic T Cells
+
Cytotoxic T cells, or CD8
T cells, are specialized in identifying and eliminating cells that display
abnormal or foreign peptides on MHC class I molecules (can be expressed by almost all nucleated
somatic cells). These include virus-infected cells and transformed tumor cells. Upon recognition,
cytotoxic T cells release granules containing perforin and granzymes that induce apoptosis in the
target cell. While essential for immune defense, inappropriate activation or persistence of cytotoxic
T cells can contribute to tissue damage in autoimmune diseases. In T1D, for example, CD8+ T cells
inltrate pancreatic islets and destroy insulin-producing β-cells, leading to loss of glucose regulation.
1.2.2.1.3 Memory T Cells
Memory T cells are a subset of antigen-experienced T cells that persist long after the initial immune
response has resolved. They can be rapidly reactivated upon re-encounter with the same antigen,
providing long-term protective immunity. Memory T cells exist in various forms, including cen-
tral memory T cells that circulate through lymphoid tissues, effector memory T cells that survey
peripheral sites, and tissue-resident memory T cells that remain in specic tissues. While generally
protective, memory T cells can sometimes perpetuate autoimmune responses if they are specic for
self-antigens, contributing to chronic inammation and relapsing disease courses.
1.2.2.1.4 Gamma Delta T Cells
Gamma delta (γδ) T cells represent a unique subset of T cells that possess a distinct TCR composed
of γ and δ chains, in contrast to the α and β chains found on conventional T cells. These cells are
less abundant in the blood but are enriched in mucosal tissues and the skin, where they provide rapid
responses to stress signals, damaged cells, and certain microbial antigens without requiring antigen
presentation by classical MHC molecules. Because of their innate-like properties, γδ T cells bridge
the innate and adaptive arms of the immune system. Their role in autoimmune diseases is still being
elucidated, but some evidence suggests they may either exacerbate or mitigate disease depending on
the context and the cytokines they produce.
1.2.2.1.5 Natural Killer T Cells
NKT cells are a distinct subset that bridge innate and adaptive immunity, sharing features of both
conventional T cells and NK cells. Unlike typical T cells that recognize peptide–MHC complexes,
NKT cells recognize lipid antigens presented by the non-classical molecule CD1d. Upon activation,
they rapidly secrete large amounts of cytokines (both pro- and anti-inammatory) enabling them to
inuence diverse immune cell populations.
NKT cells play complex roles in immune regulation and autoimmunity. While they can provide
protection, such as limiting autoimmune diabetes in some models, their dysregulation has also been
linked to autoimmune diseases like MS and systemic lupus erythematosus (SLE).
1.2.2.1.6 T Cell Activation T-cell activation occurs in secondary lymphoid organs, where naïve
+
and CD8+ T cells survey APCs, particularly DCs. Upon encountering pathogens, DCs mature
CD4
by upregulating MHC molecules, co-stimulatory ligands, and chemokine receptors, then migrate to
lymph nodes to present processed peptide antigens via MHC class I or II.
8 Bioinformatics of Autoimmune Diseases
FIGURE 1.6 T-cell activation. An antigen-presenting cell (APC) displays a pathogen-derived peptide on
its major histocompatibility complex (MHC), which is recognized by the TCR on a T cell. Full activation
requires a co-stimulatory signal provided by the interaction between the APC’s B7 ligand and the CD28
receptor on the T cell.
Activation requires two signals: rst, TCR engagement with the peptide–MHC complex; second,
co-stimulation through CD28 binding to B7 molecules (CD80/CD86) on the APC (see Figure 1.6).
Without this second signal, T cells enter anergy, a state of non-responsiveness that promotes peripheral tolerance and prevents autoimmunity.
Co-stimulatory pathways are critical in immune regulation, and their disruption can result in
autoimmunity or immunodeciency. Targeting these checkpoints is a key strategy in vaccine development and immunotherapy.
Following activation, naïve CD4+ T cells undergo differentiation into specialized effector subsets,
including Th1, Th2, Th17, Tfh cells, and regulatory T cells (Tregs), each characterized by distinct cytokine proles, transcriptional regulators, and immunological roles (see Table 1.1). The differentiation
pathway of each subset is directed by specic environmental cues, particularly cytokines produced by
APCs and surrounding tissues, and is further rened by lineage-dening transcription factors.
Th1 cells, driven by IL-12 and the transcription factor T-bet, produce IFN-γ to activate macrophages and promote immunity against intracellular pathogens. Th2 cells, induced by IL-4 and
regulated by GATA3, support humoral responses and defense against helminths and are implicated
in allergic diseases like asthma.
Th17 cells differentiate under the inuence of IL-6, IL-23, and TGF-β, with RORγt as their key
transcription factor. They secrete IL-17 to recruit neutrophils, defending mucosal surfaces against
extracellular microbes, but also contribute to autoimmunity when dysregulated.
Tfh cells, guided by Bcl6 and CXCR5, localize to germinal centers where they secrete IL-21 and
IL-4 to support B cell maturation, isotype switching, and antibody afnity enhancement.
Regulatory T cells (Tregs), marked by FoxP3, develop in the thymus or periphery and maintain
immune tolerance by secreting IL-10 and TGF-β and suppressing effector T cells through contactdependent mechanisms.
9 Immune Mechanisms and Major Autoimmune Diseases
TABLE 1.1
Major Subsets of CD4+ Helper T Cells, the Cytokines Driving Their Differentiation, the
Cytokines They Produce upon Maturation, and Their Primary Immunological Functions
T-Cell Differentiation Cytokines
Subset Cytokines Produced Main Functions
Th1
Th2 IL-4 IL-4, IL-5, IL-13 Stimulates antibodies, targets parasites, mediates allergy.
Th17
Tfh IL-6, IL-21, ICOS IL-21, IL-4 Aids B cells in class switching and afnity maturation.
Treg
Source: Zhu et al. (2010).
IL-12, IFN-γ IFN-γ, TNF-α
IL-6, IL-1β, TGF-β,
IL-23
signaling
TGF-β, IL-2 IL-10, TGF-β
IL-17A, IL-17F, Activates neutrophils, antimicrobial, autoimmunity.
IL-22
Activates macrophages for intracellular pathogen defense.
Suppresses immunity, enforces tolerance, prevents autoimmunity.
CD8+ cytotoxic T lymphocytes (CTLs), activated in secondary lymphoid tissues, recognize
antigen–MHC I complexes and eliminate infected or malignant cells. They induce apoptosis via
perforin–granzyme delivery or Fas–FasL interactions (Murphy & Weaver, 2016).
In chronic viral infections and tumor settings, sustained antigen exposure can drive T-cell
exhaustion, a dysfunctional state marked by reduced cytokine production, impaired cytotoxicity,
and persistent expression of inhibitory receptors such as PD-1, LAG-3, and TIM-3. This limits effective immune clearance in chronic disease.
Immunotherapies targeting immune checkpoints, particularly the PD-1/PD-L1 pathway, have shown
promise in reversing exhaustion and restoring T-cell function. These approaches highlight the therapeutic potential of modulating T-cell activity to enhance immunity in persistent infections and cancer.
1.2.2.2 B Cells
B cells are essential components of the adaptive immune system, responsible for producing antibodies that bind and neutralize pathogens. They develop in the bone marrow through tightly regulated
stages and express immunoglobulins (Ig) as B cell receptors (BCRs) on their surface. Each antibody
molecule (see Figure 1.7) consists of two identical heavy chains and two identical light chains, form-
ing a Y-shaped structure stabilized by disulde bonds. The variable (V) regions at the tips of the Y
form the antigen-binding sites, while the constant (C) region, particularly the Fc portion, interacts
with Fc receptors on other immune cells to trigger responses such as phagocytosis and cell lysis.
Immunoglobulin genes are not encoded as single sequences but are assembled during B cell
development through a process called V(D)J recombination. This mechanism randomly combines
gene segments (variable (V), diversity (D), and joining (J)) to create a unique variable region. The
IGH (heavy chain) locus on chromosome 14 includes V, D, J, and C segments; the IGK and IGL
(light chain) loci on chromosomes 2 and 22 include only V, J, and C segments.
The recombination is initiated by RAG-1 and RAG-2, enzymes that recognize conserved RSSs
anking each gene segment. RSSs are composed of a heptamer and a nonamer separated by a spacer
of either 12 or 23 base pairs. According to the 12/23 rule, recombination occurs only between a
segment anked by a 12 bp spacer and one anked by a 23 bp spacer. This ensures proper gene
assembly; for example, D to J must occur before V can join the DJ complex in the heavy chain. The
Artemis enzyme opens the DNA hairpins formed during cutting, and terminal deoxynucleotidyl
transferase (TdT) adds random nucleotides at the junctions, introducing junctional diversity, which
greatly expands the range of possible antibodies.
The completed immunoglobulin genes are transcribed, spliced to a constant region, and translated
into polypeptides. Heavy and light chains are then assembled and expressed as membrane-bound
10 Bioinformatics of Autoimmune Diseases
FIGURE 1.7 Structure of an immunoglobulin (antibody) molecule, consisting of two identical heavy chains
and two identical light chains. Each chain contains a variable (V) region that contributes to antigen binding
and a constant (C) region that determines isotype and effector function. The antigen-binding sites are located
at the tips of the Y-shaped molecule, formed by the pairing of variable regions from one heavy and one light
chain.
BCRs on immature B cells or secreted as antibodies by activated plasma cells. This process enables
the immune system to produce 108–1011 unique antibodies, providing protection against a vast array
of antigens. Defects in this process, such as mutations in the RAG genes, can result in severe combined immunodeciency (SCID).
There are ve antibody classes (IgM, IgG, IgA, IgE, and IgD), each dened by differences in the
heavy chain constant region. IgM is the rst antibody produced and is effective in complement activation. IgG provides long-term immunity and crosses the placenta. IgA protects mucosal surfaces
and is found in secretions like saliva and breast milk. IgE mediates allergic reactions and defense
against parasites. IgD functions primarily as a BCR on naïve B cells.
After encountering antigen in peripheral lymphoid organs, naïve B cells become activated. Full
activation requires help from Tfh cells via CD40–CD40L interaction and cytokines like IL-21.
Within germinal centers, B cells undergo two key processes: SHM and class switch recombination
(CSR), both dependent on the enzyme AID (activation-induced cytidine deaminase).
SHM introduces point mutations in the V region during proliferation in the dark zone. B cells
with higher-afnity receptors are selected in the light zone, a process called afnity maturation.
CSR, which affects the constant region of the heavy chain, allows B cells to switch isotypes (e.g.,
from IgM to IgG or IgA) without altering antigen specicity. CSR is guided by cytokines and
involves recombination between switch (S) regions, allowing antibodies to adapt their effector functions to different infections and tissues.
In autoimmunity, loss of B cell tolerance leads to the production of autoantibodies that target
self-antigens. These autoantibodies can damage tissues directly, form immune complexes, or trigger inammation through complement activation. Their presence serves as a diagnostic marker and
therapeutic target in many autoimmune diseases.
11 Immune Mechanisms and Major Autoimmune Diseases
1.2.2.3 Central Tolerance
Central tolerance eliminates or alters self-reactive lymphocytes during development, establishing
immunological self-tolerance. In the thymus, T cells that strongly bind self-antigens presented by
MHC molecules undergo apoptosis (negative selection). In the bone marrow, self-reactive B cells
are deleted or undergo receptor editing to revise antigen specicity. Defects in this process, such as
autoimmune regulator (AIRE) gene mutations, allow autoreactive cells to escape into the periphery,
leading to autoimmunity.
Peripheral tolerance acts as a secondary checkpoint to silence mature autoreactive lymphocytes.
Key mechanisms include Treg activity, T-cell anergy, and immune checkpoints. Tregs suppress
immune responses via contact-dependent pathways and cytokines like IL-10 and TGF-β. CTLA-4
competes with CD28 for B7 binding, dampening T-cell activation. PD-1, upon binding PD-L1 or
PD-L2, recruits phosphatases like SHP2 to inhibit TCR signaling and cytokine production.
Immune checkpoints (see Table 1.2) are essential for maintaining self-tolerance and limiting
tissue damage. Disruption of these pathways (by genetic variation, dysregulation, or environmental
triggers) has been implicated in autoimmune diseases.
VISTA (V-domain Ig suppressor of T-cell activation) is another inhibitory receptor expressed
on T cells and myeloid cells (see Figure 1.8). It constrains T-cell activation and promotes tolerance.
Loss of VISTA function increases susceptibility to autoimmune pathology.
When tolerance mechanisms fail, chronic inammation and autoimmune diseases emerge.
Conversely, excessive suppression of adaptive immunity can lead to persistent infections or immune evasion by tumors. Immunotherapies (such as checkpoint blockade, vaccines, monoclonal antibodies, and
adoptive T-cell transfer) are being used to restore immune balance and treat immune-mediated diseases.
In summary, adaptive immunity is governed by the interplay between activation and regulation.
Central and peripheral tolerance maintain self-tolerance, while antigen recognition, co-stimulation,
and cytokine signaling drive defense. The outcome of this balance determines immune success or
failure across health and disease.
TABLE 1.2
Key Immune Checkpoint Receptors, Their Ligands, Expression Proles, and Functional
Roles in Regulating Immune Responses
Checkpoint
Receptor Ligand(s) Expressed On Function
CTLA-4 B7-1 (CD80), B7-2 Activated T cells, regulatory Inhibits early T-cell activation in lymph nodes
(CD86) Tcells by outcompeting CD28
PD-1 PD-L1, PD-L2 Activated T cells, B cells, Inhibits T-cell activity in peripheral tissues,
NKcells promotes T-cell exhaustion
LAG-3 MHC class II Activated T cells, Tregs, Negatively regulates T-cell expansion and
NKcells function
TIM-3 Galectin-9, CEACAM1 T cells, Tregs, myeloid cells Promotes T-cell exhaustion and immune
tolerance
TIGIT CD155 (PVR), CD112 T cells, NK cells Inhibits T cell and NK cell function
VISTA VISTA (homotypic or Myeloid cells, T cells Suppresses T-cell activation, especially in
unknown) acidic tumor microenvironments
BTLA HVEM T cells, B cells Inhibitory signal, especially in naïve T cells
Source: Chen and Mellman (2017); Pardoll (2012).
Note: These molecules are essential for maintaining immune homeostasis and self-tolerance but can also be exploited by
tumors to evade immune surveillance. several checkpoints are targets of current or emerging immunotherapies.
12 Bioinformatics of Autoimmune Diseases
FIGURE 1.8 Schematic representation of immune checkpoint regulation in the immune system.
1.2.3 CYTOKINES AND CHEMOKINES
Cytokines and chemokines (see Table 1.3) are small, secreted proteins that serve as essential messengers of the immune system. They regulate cellular behaviors such as proliferation, differentiation, activation, and migration, enabling precise communication between immune and non-immune
cells. While classically associated with inammation and host defense, these mediators also play
critical roles in development, tissue repair, and homeostasis.
TABLE 1.3
Common Cytokines and Chemokines Involved in Regulating Immune Responses and Their
Roles in Autoimmune Diseases
Molecule Type Role in Autoimmune Diseases
IL-1 Cytokine Promotes inammation, activates endothelial cells, and induces fever; contributes to
tissue damage in autoimmune diseases.
TNF-α
IL-6 Cytokine Induces acute-phase response, promotes inammation, and is implicated in
IL-10 Cytokine Suppresses inammatory responses and limits tissue damage; insufcient IL-10
TGF-β
CXCL10 (IP-10) Chemokine Attracts T cells and NK cells to sites of inammation; elevated levels are associated
CCL2 (MCP-1) Chemokine Recruits monocytes and memory T cells; overexpression is linked to diseases such as
CCL5 (RANTES) Chemokine Promotes recruitment of T cells, eosinophils, and basophils; involved in chronic
CXCL8 (IL-8) Chemokine Attracts neutrophils and contributes to tissue damage; associated with inammation in
Cytokine Strong pro-inammatory mediator; drives chronic inammation and joint destruction,
especially in rheumatoid arthritis and inammatory bowel disease.
autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.
activity can lead to uncontrolled inammation in autoimmune disorders.
Cytokine Regulates immune suppression and promotes the development of regulatory T cells;
dysregulation contributes to breakdown of self-tolerance and autoimmune pathology.
with autoimmune diseases like multiple sclerosis and type 1 diabetes.
rheumatoid arthritis, lupus, and multiple sclerosis.
inammatory and autoimmune conditions including lupus and psoriasis.
diseases like rheumatoid arthritis.
13 Immune Mechanisms and Major Autoimmune Diseases
FIGURE 1.9 Flowchart illustrates the activation of immune cells leading to the expression and secretion of
cytokines and chemokines. Upon recognition of pathogens or danger signals, immune cells such as macrophages, dendritic cells, and T cells become activated, triggering intracellular signaling cascades that induce
the transcription and release of cytokines and chemokines essential for coordinating the immune response.
Their expression is tightly regulated and typically induced in response to infection, tissue injury,
or cellular stress. Recognition of PAMPs and DAMPs by PRRs, particularly TLRs, initiates intracellular signaling cascades. These pathways activate transcription factors such as NF-κB, IRFs,
and AP-1, which drive the expression of cytokine and chemokine genes (see Figure 1.9). Once
secreted, these proteins bind to specic receptors on target cells to elicit context-dependent immune
responses.
Cytokines may act in autocrine, paracrine, or endocrine fashions. Inammatory cytokines, such
as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), mediate
fever, endothelial activation, and leukocyte recruitment. In contrast, regulatory cytokines like IL-10
and TGF-β suppress excessive inammation and promote immune resolution, maintaining tissue
integrity (Opal & DePalo, 2000).
Chemokines represent a specialized subset of cytokines that direct immune cell migration
through chemotaxis. Their expression is triggered by microbial products or inammatory cytokines, and they act by binding to G protein-coupled receptors (GPCRs) on the surface of leukocytes.
This interaction reorganizes the cytoskeleton, guiding cells toward gradients of chemokine concentration. In addition to recruitment to infection sites, some chemokines are involved in immune
surveillance and the homeostatic trafcking of lymphocytes to lymphoid organs.
Figure 1.10 illustrates major cytokines and chemokines, their corresponding receptors, and the
resulting cellular responses that shape immunity and inammation.
The regulation of cytokine and chemokine signaling is vital for immune balance. Antiinammatory mediators such as IL-10 and TGF-β inhibit the production of pro-inammatory cytokines and restrain antigen-presenting cell activity. Additional control is exerted by decoy or soluble
receptors that sequester cytokines and by intracellular inhibitors such as SOCS proteins, which
block JAK–STAT signaling through negative feedback.
Disruption of these regulatory mechanisms is implicated in numerous diseases. Cytokine storms,
marked by uncontrolled release of inammatory cytokines, can cause severe tissue damage, as
seen in sepsis, viral infections like COVID-19, and autoimmune disorders. Conversely, impaired
cytokine responses may lead to immunodeciency. Aberrant chemokine signaling contributes to
chronic inammation, tumor progression, and autoimmunity by inuencing immune cell positioning, angiogenesis, and tissue remodeling.
Targeting cytokines and chemokines has become a cornerstone of modern immunotherapy.
Biologic agents that block TNF-α, IL-6, or their receptors are widely used in autoimmune diseases,
and inhibitors of chemokine receptors are under investigation for applications in cancer, HIV, and
chronic inammatory conditions. These mediators thus represent not only the language of immune
coordination but also valuable targets for clinical intervention.
Соседние файлы в папке Библиотека им академика М.И. Перельмана